ARAVIVE (ARAV)
(Real Time Quote from BATS)
$0.04 USD
0.00 (-0.25%)
Updated Jan 26, 2024 08:44 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for ARAVIVE, INC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 9 | 7 | 6 | 5 |
Cost Of Goods | NA | 0 | 0 | 0 | 0 |
Gross Profit | NA | 9 | 7 | 6 | 5 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 80 | 48 | 36 | 27 |
Income After Depreciation & Amortization | 0 | -71 | -41 | -31 | -22 |
Non-Operating Income | NA | -5 | 2 | 0 | 4 |
Interest Expense | NA | 0 | 0 | 0 | 0 |
Pretax Income | NA | -76 | -39 | -31 | -18 |
Income Taxes | NA | 0 | 0 | 0 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -76 | -39 | -31 | -18 |
Extras & Discontinued Operations | NA | 0 | 0 | 0 | 0 |
Net Income (GAAP) | NA | -76 | -39 | -31 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -70 | -40 | -29 | -21 |
Depreciation & Amortization (Cash Flow) | NA | 1 | 1 | 2 | 1 |
Income After Depreciation & Amortization | 0 | -71 | -41 | -31 | -22 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 36.37 | 20.07 | 15.79 | 11.59 |
Diluted EPS Before Non-Recurring Items | NA | -2.10 | -1.95 | -1.64 | -1.57 |
Diluted Net EPS (GAAP) | NA | -2.10 | -1.95 | -1.93 | -1.57 |
Fiscal Year end for ARAVIVE, INC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 2.76 | 1.27 |
Cost Of Goods | NA | NA | NA | 0.00 | 0.00 |
Gross Profit | NA | NA | NA | 2.76 | 1.27 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 11.67 | 13.86 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | -8.91 | -12.59 |
Non-Operating Income | NA | NA | NA | 30.14 | 30.59 |
Interest Expense | NA | NA | NA | 0.00 | 0.00 |
Pretax Income | NA | NA | NA | 21.23 | 18.01 |
Income Taxes | NA | NA | NA | 0.00 | 0.00 |
Minority Interest | NA | NA | NA | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | NA | 21.23 | 18.01 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | 21.23 | 18.01 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 76.09 | 99.64 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | -0.10 | -0.12 |
Diluted Net EPS (GAAP) | NA | NA | NA | 0.28 | -0.12 |